Safety and Efficacy of IDA for Onchocerciasis

NCT04188301 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Onchocerciasis

Interventions

DRUG: IVM w/ ALB
DRUG: Single dose of IDA
DRUG: Three daily doses of IDA

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]